EPIDEMIOLOGY AND SOCIOECONOMIC IMPACT OF SKIN-DISEASE IN LUPUS-ERYTHEMATOSUS

Citation
B. Tebbe et Ce. Orfanos, EPIDEMIOLOGY AND SOCIOECONOMIC IMPACT OF SKIN-DISEASE IN LUPUS-ERYTHEMATOSUS, Lupus, 6(2), 1997, pp. 96-104
Citations number
120
Categorie Soggetti
Rheumatology
Journal title
LupusACNP
ISSN journal
09612033
Volume
6
Issue
2
Year of publication
1997
Pages
96 - 104
Database
ISI
SICI code
0961-2033(1997)6:2<96:EASIOS>2.0.ZU;2-S
Abstract
The prevalence rates of systemic lupus erythematosus (SLE) may vary wi thin 17-48/100000 population worldwide. Although population-based epid emiological studies are still missing, the cutaneous variants of lupus erythematosus (LE) are 2-3 times more frequent than SLE itself. The m ost common age of onset is 20-40 y. Overall, cutaneous LE is regarded as a variant with less severe course and better prognosis. However, CD LE and SCLE last for many years and may lead, like SLE, to severe disa bility for work and limited life quality; also, a small proportion of patients with cutaneous LE develops SLE during the course of their dis ease. This implies considerable amount of medical management and costs for the community. Early recognition of cutaneous LE patients at risk to develop SLE and preventive measures against disease triggering fac tors are important tasks for physicians attending with cutaneous LE pa tients. It seems that signs of nephropathy, elevated ANA-titers and ar thralgias may serve as prognostic predictors for transition into SLE. Characteristic features of cutaneous LE are photosensitivity and femal e predominance. UV light is a major environmental triggering factor in cutaneous LE. Skin lesions may be induced or preexistent lesions may exacerbate due to UV light in up to 80-90% of all patients. Therefore, socioeconomic counseling of the young patients, for example choice of occupation and sun protection, are essentials in compliant patients. Also, since females are 3-6 times more frequently affected than males, the possibility of hormonal influences including pregnancy and estrog en-containing drugs should be discussed. Risk considerations for femal es wishing to become pregnant are required, and avoidance of estrogen- containing contraceptives should be recommended.